ArticleDigital journal of ophthalmology : DJO2025
Subconjunctival triamcinolone acetonide injection around lumen of XEN Gel Stent effectively resolves persistent choroidal effusion.
Article in Digital journal of ophthalmology : DJO, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The XEN Gel Stent is a minimally invasive surgical implant for glaucoma designed to reduce intraocular pressure (IOP) while minimizing hypotony by creating an aqueous outflow pathway into the subconjunctival area. The XEN stent has been shown to reduce IOP effectively, with few adverse events reported; however, complications due to hypotony, such as choroidal detachment, may still occur. We report the case of an 86-year-old woman with primary open-angle glaucoma who underwent XEN stent placement followed by Nd:YAG laser lysis to clear the fibrin-obstructed lumen. Postoperatively, she experienced refractory choroidal detachment, which progressed despite cycloplegic and frequent topical steroid treatment but was successfully managed by a subconjunctival injection of triamcinolone acetonide surrounding the bleb. This is the first reported case of subconjunctival triamcinolone acetonide injection for the management of refractory choroidal detachment after XEN placement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.